Procter & Gamble has confirmed its earnings outlook for the April to June quarter and the full-year period, and said that it was looking to see total sales growth in the high-single digit range.

The healthcare firm said earnings per share for the three-month period would fall in the $0.54 to $0.55 range, with full-year EPS coming in at around $2.64 to $2.65 – as much as 14% higher than last year. Analysts are expecting EPS of $0.55 and $2.65 for the quarter in question and twelve-month period respectively.

P&G reported EPS of $0.63 in the quarter to March 2005 – up 15% on the previous year, and on the back of a 10% hike in sales for the period to $14.3 million dollars.